Skip to main content
Erschienen in: Reactions Weekly 1/2024

01.04.2024 | Case report

Elasomeran

Massive cervical lymphadenopathy

Erschienen in: Reactions Weekly | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Ganga K, et al. Massive Cervical Lymphadenopathy Post-COVID-19 Vaccination. Ear, Nose, and Throat Journal 103: 255-257, No. 4, Apr 2024. Available from: URL: https://dx.doi.org/10.1177/01455613211048984 Ganga K, et al. Massive Cervical Lymphadenopathy Post-COVID-19 Vaccination. Ear, Nose, and Throat Journal 103: 255-257, No. 4, Apr 2024. Available from: URL: https://​dx.​doi.​org/​10.​1177/​0145561321104898​4
Metadaten
Titel
Elasomeran
Massive cervical lymphadenopathy
Publikationsdatum
01.04.2024
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2024
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-024-56823-3

Weitere Artikel der Ausgabe 1/2024

Reactions Weekly 1/2024 Zur Ausgabe

Case report

AZD-1222

Case report

Selpercatinib

Case report

Antineoplastics

Case report

Infliximab

Case report

Desmopressin